Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2025 | The importance of community physicians understanding the side effects of CAR T-cells and bispecifics

Gloria Iacoboni • 4 Sep 2025
SOHO 2025
General Antibodies CAR-T

Gloria Iacoboni, MD, PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, discusses the importance of community physicians understanding the potential toxicities associated with CAR T-cell therapy and bispecific antibodies, highlighting the need to be familiar with cytokine release syndrome (CRS), neurologic toxicities, cytopenias, and infections. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Gloria Iacoboni

Evolving role of CAR-T and bispecifics in B-cell lymphoma: from R/R to frontline 2:35
Evolving role of CAR-T and bispecifics in B-cell lymphoma: from R/R to frontline
Gloria Iacoboni • 4 Sep 2025
Holding and bridging therapy selection in R/R aggressive B-cell lymphoma 2:56
Holding and bridging therapy selection in R/R aggressive B-cell lymphoma
Gloria Iacoboni • 4 Sep 2025
How the CNS-IPI score may be used to predict the risk of ICANS after CAR T-cell therapy 1:21
How the CNS-IPI score may be used to predict the risk of ICANS after CAR T-cell therapy
Gloria Iacoboni • 4 Sep 2025
Sequencing therapies in R/R DLBCL, MCL & FL: CAR-T, bispecifics, BTK inhibitors & more 48:01
Sequencing therapies in R/R DLBCL, MCL & FL: CAR-T, bispecifics, BTK inhibitors & more
Gloria Iacoboni et al. • 28 Mar 2025

Related Videos

Opportunities and challenges for real-time AI decision support in transplant care 4:47
Opportunities and challenges for real-time AI decision support in transplant care
Amin Turki • 5 Sep 2025
How AI and digital innovation are transforming transplant care 4:02
How AI and digital innovation are transforming transplant care
Amin Turki • 5 Sep 2025
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute 1:01
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute
Krish Patel • 4 Sep 2025
Stem cell transplant in 2025: latest advances, improving GvHD, and key clinical trials 8:12
Stem cell transplant in 2025: latest advances, improving GvHD, and key clinical trials
Alexandra Gomez-Arteaga • 10 Sep 2025
The content of VJHemOnc is intended for healthcare professionals